• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

NCPA Renews Recommendation of Prescryptive AI Pricing: Empowering Pharmacies with AI-Driven Cash Pricing

by Fred Pennic 05/02/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Prescryptive Health, a leading healthcare technology company, today announced the National Community Pharmacists Association’s (NCPA) renewed endorsement of Prescryptive AI Pricing. 

– Prescryptive AI Pricing creates a dynamic and competitive cash pricing system, enabling independent pharmacies to thrive in the ever-evolving healthcare landscape. This AI-powered solution empowers independent pharmacies to optimize cash pricing and enhance their competitive edge.

NCPA Recognizes Value of AI for Pharmacies

NCPA first recommended Prescryptive AI Pricing in 2022, acknowledging its potential to revolutionize cash pricing strategies for independent pharmacies. This renewed endorsement underscores NCPA’s ongoing commitment to supporting its members with innovative solutions.

Data-Driven Profitability: AI Delivers Results

Prescryptive Health recently released compelling data highlighting the significant profitability improvements pharmacies experience with Prescryptive AI Pricing. Their analysis revealed an impressive gross profit margin of nearly 54% in 2023 for pharmacies utilizing the solution.

Independent Pharmacies in a Cash-Driven Landscape

The rise of high-deductible health plans has led to a significant increase in cash-paying customers at pharmacies. Traditional cash discount cards often result in financial losses for pharmacies. Prescryptive AI Pricing offers a powerful alternative.

AI-powered Cash Pricing Optimization

This innovative solution leverages a pharmacy’s own data and customizable parameters. Advanced analytics and actionable insights empower pharmacies to strategically position themselves within the cash pricing market.

“As the voice of the community pharmacist, we know the major headwinds that America’s community pharmacies are facing,” said Douglas Hoey, CEO of NCPA. “As our community pharmacies battle reimbursement challenges, our NCPA member pharmacies can use Prescryptive AI Pricing to remain competitive while also continuing to do what they do best: take care of their patients.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Pharmacy

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |